180 related articles for article (PubMed ID: 36468633)
21. Clinical significance of incidental finding of focal activity in the breast at 18F-FDG PET/CT.
Kang BJ; Lee JH; Yoo IeR; Kim SH; Choi JJ; Jeong SH; Yim HW
AJR Am J Roentgenol; 2011 Aug; 197(2):341-7. PubMed ID: 21785079
[TBL] [Abstract][Full Text] [Related]
22. Role of
Dolci C; Ceppi L; Guerra L; Crivellaro C; Lamanna M; Adorni M; Elisei F; Bonazzi CM; Sina F; Fruscio R; Messa C
Int J Gynecol Cancer; 2019 Oct; 29(8):1298-1303. PubMed ID: 31366569
[TBL] [Abstract][Full Text] [Related]
23. The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patients.
Barrio M; Czernin J; Yeh MW; Palma Diaz MF; Gupta P; Allen-Auerbach M; Schiepers C; Herrmann K
Nucl Med Commun; 2016 Dec; 37(12):1290-1296. PubMed ID: 27612034
[TBL] [Abstract][Full Text] [Related]
24. Whole-body
Gajjala SR; Hulikal N; Kadiyala S; Kottu R; Kalawat T
Indian J Med Res; 2018 Mar; 147(3):256-262. PubMed ID: 29923514
[TBL] [Abstract][Full Text] [Related]
25. [Frequency of malignancy in thyroid incidentalomas detected by whole body 18F-FDG PET/CT].
Ladrón de Guevara H D; Munizaga M C; García S N; Letelier B C; Wash F A
Rev Med Chil; 2020 Jan; 148(1):10-16. PubMed ID: 32730431
[TBL] [Abstract][Full Text] [Related]
26. The role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography whole body imaging in the evaluation of focal thyroid incidentaloma.
Zhai G; Zhang M; Xu H; Zhu C; Li B
J Endocrinol Invest; 2010 Mar; 33(3):151-5. PubMed ID: 19783895
[TBL] [Abstract][Full Text] [Related]
27. Factors affecting the accuracy of
Kutluturk K; Simsek A; Comak A; Gonultas F; Unal B; Kekilli E
Niger J Clin Pract; 2019 Jan; 22(1):63-68. PubMed ID: 30666022
[TBL] [Abstract][Full Text] [Related]
28. A risk-adapted approach using US features and FNA results in the management of thyroid incidentalomas identified by 18F-FDG PET.
Choi JS; Choi Y; Kim EK; Yoon JH; Youk JH; Han KH; Moon HJ; Kang WJ; Kwak JY
Ultraschall Med; 2014 Feb; 35(1):51-8. PubMed ID: 24458573
[TBL] [Abstract][Full Text] [Related]
29. Subtype-Guided
Wu S; Wang Y; Li J; Zhang N; Mo M; Klimberg S; Kaklamani V; Cochet A; Shao Z; Cheng J; Liu G
Oncologist; 2020 Apr; 25(4):e626-e633. PubMed ID: 32297448
[TBL] [Abstract][Full Text] [Related]
30. The frequency and malignancy rate of incidental focal breast lesions identified by 18F-fluorodeoxyglucose positron emission tomography.
Andersen JD; Zacho HD; Petersen LJ
Nucl Med Commun; 2021 Jan; 42(1):93-100. PubMed ID: 33044407
[TBL] [Abstract][Full Text] [Related]
31. Thyroid incidentalomas detected on 18F-fluorodeoxyglucose-positron emission tomography/computed tomography: Thyroid Imaging Reporting and Data System (TIRADS) in the diagnosis and management of patients.
Yoon JH; Cho A; Lee HS; Kim EK; Moon HJ; Kwak JY
Surgery; 2015 Nov; 158(5):1314-22. PubMed ID: 25958065
[TBL] [Abstract][Full Text] [Related]
32. Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography.
Chun AR; Jo HM; Lee SH; Chun HW; Park JM; Kim KJ; Jung CH; Mok JO; Kang SK; Kim CH; Kim BY
Endocrinol Metab (Seoul); 2015 Mar; 30(1):71-7. PubMed ID: 25325277
[TBL] [Abstract][Full Text] [Related]
33. PET/CT incidental detection of second tumor in patients investigated for pancreatic neoplasms.
Moletta L; Bissoli S; Fantin A; Passuello N; Valmasoni M; Sperti C
BMC Cancer; 2018 May; 18(1):531. PubMed ID: 29728085
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of clinically significant incidental findings by whole-body fludeoxyglucose F 18 positron emission tomography/computed tomography scanning in moderate-to-severe psoriasis patients participating in clinical trials.
Wan MT; Torigian DA; Alavi A; Alvarez J; Chiesa Fuxench ZC; Noe MH; Papadopoulos M; Shin DB; Takeshita J; Werner TJ; Mehta NN; Gelfand JM
J Am Acad Dermatol; 2019 Jun; 80(6):1630-1639. PubMed ID: 30654078
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of Colonoscopic Results of Patients with Incidental Colonic FDG Uptake in PET/CT Imaging.
Esmer AC; Öksüzoğlu K; Şen F; Yazıcı H; Tazeoğlu D; Ergelen R; Öneş T; Yeğen ŞC
World J Surg; 2023 Oct; 47(10):2532-2541. PubMed ID: 37516690
[TBL] [Abstract][Full Text] [Related]
36. Comparison of
Mori M; Fujioka T; Ichikawa R; Inomata R; Katsuta L; Yashima Y; Yamaga E; Tsuchiya J; Hayashi K; Kumaki Y; Oda G; Nakagawa T; Onishi I; Kubota K; Tateishi U
Tomography; 2022 Oct; 8(5):2533-2546. PubMed ID: 36287810
[TBL] [Abstract][Full Text] [Related]
37. Thyroid incidentalomas in FDG-PET/CT: prevalence and clinical impact.
Bonabi S; Schmidt F; Broglie MA; Haile SR; Stoeckli SJ
Eur Arch Otorhinolaryngol; 2012 Dec; 269(12):2555-60. PubMed ID: 22298251
[TBL] [Abstract][Full Text] [Related]
38. Incidental focal FDG uptake in the parotid glands on PET/CT in patients with head and neck malignancy.
Seo YL; Yoon DY; Baek S; Lim KJ; Yun EJ; Cho YK; Bae WJ; Chung EJ; Kwon KH
Eur Radiol; 2015 Jan; 25(1):171-7. PubMed ID: 25182627
[TBL] [Abstract][Full Text] [Related]
39. The Proportion of Malignancy in Incidental Thyroid Lesions on 18-FDG PET Study: A Systematic Review and Meta-analysis.
Nayan S; Ramakrishna J; Gupta MK
Otolaryngol Head Neck Surg; 2014 Aug; 151(2):190-200. PubMed ID: 24759908
[TBL] [Abstract][Full Text] [Related]
40. MRI fused with prone FDG PET/CT improves the primary tumour staging of patients with breast cancer.
Garcia-Velloso MJ; Ribelles MJ; Rodriguez M; Fernandez-Montero A; Sancho L; Prieto E; Santisteban M; Rodriguez-Spiteri N; Idoate MA; Martinez-Regueira F; Elizalde A; Pina LJ
Eur Radiol; 2017 Aug; 27(8):3190-3198. PubMed ID: 28004161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
